Log in
Enquire now
‌

US Patent 10072094 Compositions and methods for tumor transduction

Patent 10072094 was granted and assigned to Aleta Biotherapeutics on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Aleta Biotherapeutics
Current Assignee
‌
Aleta Biotherapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10072094
Date of Patent
September 11, 2018
Patent Application Number
15670535
Date Filed
August 7, 2017
Patent Citations Received
‌
US Patent 10669349 Compositions and methods for treatment of cancer
Patent Primary Examiner
‌
Robert M Kelly
Patent abstract

The invention relates to cancer therapeutics, in particular, the system of making cancer cells more susceptible to effector cells by introduction of cellular therapy targets into the cancer cells.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10072094 Compositions and methods for tumor transduction

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.